Goodwin Procter advised Wellth, Inc. on the deal. Wellth, Inc. announced its $20 million Series B financing round led by SignalFire. Headquartered in Los Angeles, California,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Eluminex Biosciences on the deal. Eluminex Biosciences (Suzhou) Limited (Eluminex) announced its acquisition of certain assets and the related global development and commercialization rights...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Qilu Pharmaceutical on the deal. Qilu Pharmaceutical, one of the leading pharmaceutical companies in China (“Qilu”), announced its exclusive licensing agreement and strategic partnership...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz and Willkie Farr & Gallagher advised Constellation on the deal. Goodwin Procter, Dechert and Maiwald acted as legal advisors to Royalty...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Chiasma, Inc. on the deal. Chiasma, Inc. (Nasdaq: CHMA) announced its definitive agreement to be acquired by Amryt Pharma plc (Nasdaq: AMYT, AIM:...
You must be a Standard 1 Year member to access this content.
